Insider: FOSTER JAMES C Chairman, President and CEO - CHARLES RIVER LABORATORIES INTERNATIONAL INC
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 183,639 | 750 | 184,389 |
| Value | $26,732,329.23 | $109,177.50 | $26,841,506.73 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 02/20/2025 | AAP | 6,075 | Direct | COM | $165.01 | $1,002,435.75 | 183,639 |
| 08/01/2024 | DDS | 25,000 | Direct | COM | $250.00 | $6,250,000.00 | 188,251 |
| 11/14/2023 | AAP | 5,620 | Direct | COM | $178.05 | $1,000,641.00 | 202,643 |
| 02/15/2023 | DDS | 19,892 | Direct | COM | $250.00 | $4,973,000.00 | 216,702 |
| 02/15/2023 | DDS | 108 | Direct | COM | $250.16 | $27,017.28 | 216,594 |
| 02/23/2022 | DDS | 3,171 | Direct | COM | $287.10 | $910,388.39 | 225,202 |
| 02/23/2022 | DDS | 4,245 | Direct | COM | $287.84 | $1,221,888.87 | 220,957 |
| 02/23/2022 | DDS | 2,027 | Direct | COM | $286.06 | $579,844.63 | 228,373 |
| 02/23/2022 | DDS | 805 | Direct | COM | $288.82 | $232,500.91 | 220,152 |
| 02/23/2022 | DDS | 1,503 | Direct | COM | $283.89 | $426,683.06 | 233,815 |
| 02/23/2022 | DDS | 3,415 | Direct | COM | $284.79 | $972,542.48 | 230,400 |
| 02/23/2022 | DDS | 1,259 | Direct | COM | $291.05 | $366,436.48 | 217,815 |
| 02/23/2022 | DDS | 389 | Direct | COM | $294.70 | $114,636.86 | 215,374 |
| 02/23/2022 | DDS | 352 | Direct | COM | $295.70 | $104,084.85 | 215,022 |
| 02/23/2022 | DDS | 1,078 | Direct | COM | $290.01 | $312,632.94 | 219,074 |
| 02/23/2022 | DDS | 325 | Direct | COM | $293.81 | $95,488.84 | 215,763 |
| 02/23/2022 | DDS | 746 | Direct | COM | $292.87 | $218,478.48 | 216,088 |
| 02/23/2022 | DDS | 981 | Direct | COM | $291.81 | $286,262.67 | 216,834 |
| 02/22/2022 | DDS | 5,243 | Direct | COM | $288.12 | $1,510,587.99 | 225,795 |
| 02/22/2022 | DDS | 4,472 | Direct | COM | $288.86 | $1,291,763.14 | 221,323 |
| 02/22/2022 | DDS | 796 | Direct | COM | $285.88 | $227,560.80 | 233,432 |
| 02/22/2022 | DDS | 2,394 | Direct | COM | $286.93 | $686,919.28 | 231,038 |
| 02/22/2022 | DDS | 2,600 | Direct | COM | $290.03 | $754,085.28 | 218,723 |
| 02/22/2022 | DDS | 100 | Direct | COM | $291.50 | $29,150.00 | 217,142 |
| 02/22/2022 | DDS | 350 | Direct | COM | $292.74 | $102,460.02 | 216,792 |
| 1 2 3 4 5 6 7 8 9 10 Next Last You are at page 1 of 127 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research